GlassScriptPhysician profile
Mynon E Mitton
NPI 1235722620
$4,738.26
in general payments reported to CMS, 2019-2025
32 companies · $3,345 in 2025
The $3,345 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.23 · 2022: $553 · 2023: $630 · 2024: $198 · 2025: $3,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,968 · Travel and Lodging: $1,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,967.69 |
| Travel and Lodging | $1,205.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,076.92 | 2022-2025 | Proclaim, Thoratec Heartmate 3 Lvas Implant Kit, Octrode |
| Protega Pharmaceutials INC | $369.78 | 2025 | Roxybond |
| Abbvie INC. | $339.35 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $201.50 | 2022-2023 | Farxiga, Airsupra, Breztri |
| Biotronik Nro, INC. | $199.80 | 2025 | Prospera |
| Boston Scientific Corporation | $198.58 | 2025 | Intracept, Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Novo Nordisk INC | $190.02 | 2022-2023 | Ozempic, Rybelsus |
| Nalu Medical, INC. | $146.68 | 2025 | Nalu Neurostimulation System |
| Glaxosmithkline, LLC. | $127.27 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Vertex Pharmaceuticals Incorporated | $113.62 | 2025 | |
| Tonix Medicines, INC. | $105.46 | 2025 | Tonmya |
| Collegium Pharmaceutical, INC. | $67.66 | 2025 | Belbuca, Xtampza |
| Corium, LLC | $61.41 | 2024 | Azstarys |
| Sanofi-Aventis U.S. LLC | $55.19 | 2022 | |
| Medtronic, INC. | $43.59 | 2025 | Inceptiv |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lucid Diagnostics INC. | $42.42 | 2022-2023 | |
| Exact Sciences Corporation | $39.09 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $35.50 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.98 | 2025 | Relistor |
| Pfizer INC. | $33.29 | 2023 | |
| Lilly USA, LLC | $32.12 | 2022 | |
| Edwards Lifesciences Corporation | $31.68 | 2022 | |
| Astellas Pharma US INC | $31.66 | 2023 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.20 | 2022 | |
| Nevro Corp. | $23.51 | 2023 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $20.79 | 2022 | |
| Therapeuticsmd, INC. | $16.77 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.56 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.93 | 2022 | |
| Dexcom, INC. | $13.63 | 2022 | |
| Hikma Pharmaceuticals USA | $13.07 | 2022 | |
| Merck Sharp & Dohme LLC | $12.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mynon Mitton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.